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Analysis of multiple genes expressed in the murine eye and lymphatic
system during embryonic development.
Beth A. Bowling, University of Tennessee, Knoxville
Dr. Guillermo Oliver, Dr. Oleg Lagutin, Dr. Natasha Harvey, Michelle Self, Jaime
Morgan, S1. Jude Children's Research Hospita~ Memphis, TN
Dr. Jeffery MacCabe, University of Tennessee, Knoxville

Abstract:
My senior research project was completed at S1. Jude Children's Research
Hospital in Memphis, TN. I did my work in the Genetics department in the lab of Dr.
Guillermo Oliver during the summers of2001 and 2002. Dr. Oliver's lab uses mice as a
model to study developmental genetics and embryology. I had a different project each
summer, and both of these projects are related in many aspects. The overall goal of both
of my projects was to try to understand the function of genes that are expressed in the
developing mouse embryo. The first summer I focused mostly on the gene Six 2, and the
second summer I focused on gaining a better understanding three genes expressed in the
developing lymphatic system. The first summer I learned a tremendous amount about
cloning techniques, and I make a the knockout construct for the gene Six 2. The second
summer I made the conditional knockout construct for the gene Prox 1, since the
complete knockout is lethal before birth. I undertook another project the second summer,
which was very educationa~ but unfortunately unsuccessful. In this project, I attempted
to do a yeast two-hybrid screening of a mouse E 10.5 cDNA library to look for genes
whose protein products physically interacted with the products of VEGF-C and Flt-4.
Although many of the results of these experiments are not complete, I think they will be
very interesting.
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The Six family of homeo box genes acts as transcription factors activating other
genes, and initiating some developmental processes (1). The Six family of genes are
evolutionarily conserved and can be found in organisms ranging from Drosophila to
humans (1). The Six family was identified with the discovery of its fIrst member,

Drosphila sine oculus, a gene very important in compound eye formation (1).
Most members of the Six family contain a very similar domain called the "Six
Domain," which contains 110-115 amino acids. Since these genes are also homeobox
genes, they also contain a conserved homeodomain which is around sixty amino acids in
length. This family's homeodomain is quite unique when compared to that of other
homeobox genes. The domain does not include an arginine at position five or a
glutamine at position twelve in the first helix. These residues are usually responsible for
the binding of the transcription factor to the T AAT binding sequence. So, as would be
expected, the Six family of genes does not bind to DNA containing the T AAT sequence.

Six 2 is one of the members of this family, and this is the gene on which part of
my project was focused. Six 2 is located on mouse chromosome 17, and its expression is
not seen before day E8.5 in development (2). So far only a single transcript of Six 2 has
been found, which is approximately 2.3 K.B (2). Six 2 is expressed largely in the
developing connective tissues of the body such as tendons (2). However Six 2 is also
expressed in the sensory placodes of early embryos around E9.5, which will later give
rise to the eyes and the ear (1). Other areas of Six 2 expression include the head
mesenchyme E8.5, brachial arches E9.5, primitive kidneys EI0.5, and genitals Ell.5 (2).
To try and better understand the function of the gene, I began a loss of function
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experiment or a knockout. When I arrived, Dr. Oleg Lagutin had already cloned the
genomic fragment of Six 2 into a plasmid he named CESI. He had also designed the
construct, and the majority of my project was creating this knockout construct.
First, I started with the plasmid CES1 (Six 2) which was digested with EcoRl to
obtain the 2.S K.B. and 1.6 K.B. Six 2 I EcoRl fragments. These fragments were isolated
using gel electrophoresis and gel extraction of the DNA. The 2.S K.B. fragment was
used as the 3' arm of the knockout construct. The 1.6 K.B. fragment was used to detect
the proper recombination of the construct with the genomic DNA. Both of these
fragments were cloned separately into the vector pbluescript II KS. In preparation for
this cloning, pbluescript II KS was digested with EcoRl to linearize the vector. Next, the
S' phosphates were removed to prevent self-ligation of the vector. The two EcoRl
fragments were ligated (sticky/nondirectional) into separate vectors resulting in plasmid
CI, which contains the 2.S K.B. Fragment, and CJ, which contains the 1.6 K.B. fragment.
The purpose of creating CI was to conveniently modify the 3' arm by removing a

Hind III site, without altering the final construct. The removal of the Hind III site within
the 3' arm was used as part of the strategy to detect correct construct genomic
recombination. To remove this site, CI was partially digested with Hind III. Gel
electrophoresis and extraction of the DNA was preformed to isolate the fragments only
cut once in the desired place. The ends were then blunted with Klenow, and the plasmid
was self-ligated. This self-ligation will result in the elimination of the Hind III site in the
3' arm of the construct, and they new plasmid was called CK.
The vector for the final construct, pKO Scrambler NTKV -1901, contains two
scrambler sites for the introduction of the S' and 3' arms of the construct. It also contains
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a neomycin resistance gene as positive selection and thymidine kinase as negative
selection. This vector was digested with EcoRl and dephosphorylated at the scrambler B
site. CK was digested with EcoRl to remove the 2.5 K.B. 3' arm of the construct. Both
the vector and insert were ran out on an agarose gel and purified by gel extraction to be
ligated together (sticky/nondirectional). The resulting plasmid is called CL.
CESI was used again to obtain the 5' arm of the construct. CESI was digested
with Nco 1, which will linearize the plasmid, and Klenow was used to blunt the ends of
the fragment. It was then digested with Hind III. The 5' arm of the construct can be
isolated as a 6.2 K.B. fragment upon gel electrophoresis and extraction of the DNA. CL,
which is pKO scratnbler NTKV-1901 already containing the 3' arm, was first digested
with Xho 1, and the ends were blunted with Klenow. It was then digested with Hind III.
The ends of the insert and vector were blunted due to the incompatibility of the Nco 1 and
Xho 1 ends. A ligation was set and the resulting plasmid was the fmal construct and
named CM (blunt/sticky/directional). This construct was sequenced and all junctions
were correct, so I concluded that CM was the desired fmal Six 2 knockout construct.
Appendix page 1 shows CM map, and page 2 details how the construct will recombine
with the genomic DNA.
The proper recombination of the construct with the genomic DNA will be
detected using CJ, which contains the 1.6 K.B. EcoRl fragment that will be used as a
probe in a Southern blot. After electroporation of the embryonic stem cells, the genomic
DNA will be digested with Hind III, and the radioactive probe will be used to identify the
fragment that includes the 1.6 K.B. probe area. If recombination has occurred in the
proper place, then one of the Hind III sites will be absent and the probe will adhere to a
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larger fragment. If the construct has not recombined in the proper place, then the probe
will adhere to a 3.0 K.B. fragment.
Another member of the lab, Michelle Self, took over the Six 2 knockout project
while I returned to school. She did the electroporation of the embryonic stem cells and
selected cells that had undergone the proper recombination with the knockout construct.
The original plan was for me to return to St. Jude the next summer and analyze the Six 2
mutants, but unfortunately the knockout mice were not rom in time for me to analyze
them.

Results & Discussion:
On October 2,2002 I received notification that the first Six 2 knockout litter had
been rom and the mice died at birth. The mice appeared to be normal from the exterior
of the rody, but upon dissection, it was discovered that the mice had no kidneys.
Preliminary analysis has shown that the mesonephros and metanephros are present E9.5
through E 14.5. The metanephros, which would persist to function as the kidney
degenerates sometime between E 14.5 and birth.
Another phenotype of the knockout has recently been discovered. Although this
is preliminary data, it seems as if all the cells in the retina look morphologically
abnormal. It has been hypothesized that there is a defect in amacrine cell differentiation.
Experiments are currently being performed to better understand this.
There are still a tremendous number of experiments to be done. It would be very
interesting to see how the connective tissues of the knockout mice are affected, since Six
2 is highly expressed in this tissue (2). I am also anxiously awaiting the results of
experiments which detail how the expression of other genes are affected by the absence
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of Six 2. These experiments would help to elucidate developmental pathways. Since this
gene is a transcription factor, it is expected to affect to have some very interesting results.
I also think it would be beneficial to make a conditional knockout, since the mutation is
lethal. This is the same type of experiment that I did in another part of my project, and it
will allow us to see the tissue specific effects of the gene while avoiding lethality.
Although my aspect of the project is fInished, I plan to keep in touch with the lab and
stay updated on any new results that are obtained.

Proxl
The next gene studied was Proxl, a vertebrate homeobox gene related to the

Drosophila gene prospero (3). Proxl is expressed in the eNS, liver, heart, lens, retina,
pancreas, skeletal muscle, and lymphatic endothelial cells of mice (3). The polarized
expression of this gene by a subset of cells the cardinal vein gives these cells a bias
towards becoming lymphatic tissue (4). Upon the expression of other genes, one of
which will be discussed later, these cells bud off and become the first lymphatic
endothelial cells (4). A knockout of Proxl was developed, and the mice died before birth
(3). Analysis of the knockout embryos showed that cells did begin to bud from the
cardinal vein, but did not continue to develop into lymphatic vessels (3). It was
concluded that Proxl expression is required to maintain budding and develop lymphatics

(3).
Analysis of Proxl heterozygotes has been done, and it has yielded some
interesting results, all of which indicate a disruption in lymphatic development (3). The
mice have lymph edema, a build up of chyle in the intestines, and abnonnalities in the
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positions of lymphatic vessels (see appendix page 3) (3). It is desirable to make a
conditional knockout of Proxl to see how inactivating the gene at particular times and
places in development will affect the tissue while avoiding lethality.
Dr. Natasha Harvey had already designed the construct and cloned part of the
genomic sequence of Prox 1 in plasmids P23 and P5. My job was to execute the plans
and create the knock-out construct. The frrst step was to cut the 3' arm of the construct
out of the P23 plasmid. This arm contains exons 2 and 3 of the Prox 1 gene. P23 was
digested with Cia I (sticky) and EcoRV (blunt) to generate the 8.8 KB insert fragment.
Then next step was to digest the vector, pNeotkLoxP, with Sal I and then blunt the end
with Klenow. The vector was digested with CIa 1. The fIrst ligation was set with the 3'
arm and pNeotkLoxP (directionallstickylblunt). To prepare for the ligation of the 5' arm
into the construct P5 was digested with Not I and blunted with Klenow. This generates
the 2.2 KB insert fragment. To prepare the vector for this ligation, pNeotkLoxP + 3' arm
was digested with EcoRV (blunt) and Hind III, which was blunted with Klenow. The
second ligation is a blunt, nondirectionalligation.
The next steps for the conditional knockout will be to electroporate the embryonic
stem cells and select cells which have under gone the proper recombination. Dr. Harvey
introduced LoxP sites into the intron sequence of Prox 1 as can be seen in figure 1 on the
next page. When the construct recombines with the genomic DNA it will appear as in the
frrst line of the figure. When a mouse who is homozygous for the Prox 1 conditional
knockout is crossed with a line of CreLoxP mice, their offspring will be the ones to
express the desired phenotype. Depending on the line of Cre mice the used, Cre
recombinase will be expressed in a certain tissue, at a certain time and cleavage of the
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construct will occur. The ultimate result will be the bottom line, in which Prox 1 is not
functional due to the removal of exons 2 and 3.

2
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Figure 1. This describes the way this construct will work in a developing embryo expressing CreRecombinase. The
end result will be the cleavage and removal of exons 2 and 3. This will leave Prox 1 nonfunctional.

Results & Discussion:
After three ligation attempts, one arm of the Proxl conditional knockout was
successfully ligated in the proper orientation. When I left St. Jude, colonies were still
being screened to see if any of the ligations for the second arm were successful. I was
notified in September that a colony hybridization revealed that the construct was
complete. Sequencing has been ordered to check the junctions in the construct. Dr.
Natasha Harvey has taken over the project, and I expect to have the first Prox 1
conditional knockout mouse around December 2003.

VEGF... C and Flt-4 Yeast-two hybrid library screening
The other genes being studied in the yeast-two hybrid library screening are Flt-4
and VEGF-C. Flt-4 (also known as VEGFR-3) is first expressed in developing blood
vessels and later in lymphatics (4). Flt-4 is a vascular endothelial growth factor receptor.
It is one of the fITst genes expressed by cells that bud off from the cardinal vein to

develop into lymphatics (4). Later in adulthood, Flt-4 is expression is restricted to
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lymphatic tissue (4). A missense mutation in Flt-4 results in a genetic disorder called
Milroy disease (4). This disease results in lymph edema and is due to a missense
mutation that disrupts the tyrosine kinase activity of Flt-4 (see figure 2 below) (4).

VEGF-C is a vascular endothelial growth factor, and it is the ligand of Flt-4 (4). Over
expression of this gene induces lymphangiogenesis, which could be important in tumor
growth and metastasis (4).

It would be interesting to see what other proteins or co-

factors these molecules bind, since they are both present in lymphatic vessels. This will
be accomplished by a yeast-two-hybrid library screening.

,

R
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Fig. 4. 9 year-old girl with chylous reflux and left leg
lymphedema. Injection of radiotracer only into the Tight
foot refluxes into the left
aU the
to the foot.
Figure 2. A 9 year old child with Milroy Disease. Note the lymph
edema that results from a mutation in Flt-4.

Flt-4 and VEGF-C DNA was obtained for the library screening constructs by RTPCR from eDNA. The PCR primers were designed to incorporate an additional Not I and

Sal I site on the ends of the fragment to facilitate future cloning. The PCR products were
ligated into pgem-T -easy because the PCRs were very sensitive, and only small amounts
of DNA could be made. The next step was to clone the genes into the vector that would
be used for the library screening, PC97B.
The library screening will help to identify any genes in the mouse EI0.5 eDNA
library that physically interact with the bait gene (VEGF-C or Flt-4). This is done by
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cloning genes in frame with domains of a transcription factor. The only way that the
transcription factor can activate its target gene is if the bait protein and the library protein
bind to one another. The concept is that if the bait and library proteins interact the two
domains of the transcription factor will be in the correct locations to activate the reporter
genes.

A figure on appendix page 4 illustrates this concept. The reporter genes were

lac Z, HIS 3, and URA 3. The lac Z provided the opportunity to use IPTG and X-GAL to
test for positive (blue) colonies. The HIS 3 and URA 3 genes allowed for selection of
positive colonies as ones that can survive on plates lacking histidine and uracil.
Results & Discussion

Seven ligation attempts were made to ligate Flt-4 into PC97B, and none were
successful. VEGF-C was cloned parallel to Flt-4, and the second ligation attempt was
successful for VEGF-C. During this time both genes were sequenced in pgem-T-easy,
and both were found to have missence and nonsense mutations as a result of PCR.
Unfortunately due to the sensitivity of the reactions, none of the high fidelity polymerases
worked. The PCRs were very hard to optimize, and successful reactions were not
reproducible. The mutation in Flt-4 produced a stop codon in the middle of the sequence,
so this clearly means that we must go back and obtain Flt-4 sequence that is not mutated
either by PCR or other means. At the end of my time at St. Jude, no clonings of Flt-4 had
been done without mutations. In order for the library screening to be successful, a fully
functional protein had to be produced, so this project has not made any significant
progress. There were two mutations in VEGF-C. One involved changing a tyrosine to
methionine and the other changed a proline to leucine. These mutations are clearly not
extreme changes, and they are not in functional or conserved domains. However, since
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wild-type protein conformation is essential in this experiment the results obtained using
the mutated constructs would have to be repeated to confirm that there is an interaction
between the wild-type VEGF-C and the library protein. When the sequencing errors
were discovered, the VEGF-C library screening was already underway. Nineteen clones
had passed the His selection and other screenings were underway. New VEGF-C PCR
cloning attempts were also started.

Currently another member of the lab, Jaime Morgan,

is attempting to clone both of these genes, and she has had no success.
Conclusion:

The fmal result of my senior research project, as of Nov. 14,2002 is to have
developed the knock out construct for Six 2 and the conditional knock out construct for
Prox 1. Overall, I feel that my project was a success most importantly because I learned

so much information in those two summers. I also feel that in doing my project I utilized
and combined the information from almost all of my classes, and it was truly an
educational conclusion to my undergraduate education.
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